99% Savings - Buy Just @1 Rs X
Renvela 800 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Increased Phosphate Levels in the Blood. Renvela 800 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Renvela 800 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Renvela 800 Mg Tablet as well, which are listed below. Such side effects of Renvela 800 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Renvela 800 Mg Tablet's effect during pregnancy is Unknown and Safe while nursing. In addition, Renvela 800 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Renvela 800 Mg Tablet related warnings section.
Renvela 800 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Renvela 800 Mg Tablet in conditions like Intestinal Obstruction. The section on Renvela 800 Mg Tablet contraindications lists all such conditions.
Besides this, Renvela 800 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Renvela 800 Mg Tablet is safe while driving, and is is addictive in nature.
Renvela 800 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Renvela 800 Mg Tablet safe for pregnant women?
It is not known what effect Renvela will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Renvela 800 Mg Tablet safe during breastfeeding?
Renvela is safe for breastfeeding women.
What is the effect of Renvela 800 Mg Tablet on the Kidneys?
Renvela has very mild side effects on the kidneys.
What is the effect of Renvela 800 Mg Tablet on the Liver?
There is no research available on the side effects of Renvela on the liver. Therefore, its impact is unknown.
What is the effect of Renvela 800 Mg Tablet on the Heart?
Information about safety of Renvela for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Renvela 800 Mg Tablet unless your doctor advises you to do so -
Is this Renvela 800 Mg Tablet habit forming or addictive?
No, you will not get addicted to Renvela 800 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Renvela 800 Mg Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Renvela 800 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
No, the use of Renvela 800 Mg Tablet in mental disorders is not effective.
Interaction between Food and Renvela 800 Mg Tablet
Due to a lack of research, nothing can be said about the consequences of taking Renvela 800 Mg Tablet together with food.
Interaction between Alcohol and Renvela 800 Mg Tablet
It is difficult to say anything about the effect of Renvela 800 Mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135